Researchers studied the trends in alcohol use after the COVID-19 pandemic, comparing data from 2018, 2020 and 2022.

A new study has found that the groundbreaking new class of weight loss drugs may not only be good at treating diabetes, but ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.

A recent study conducted in Sweden found that GLP-1 agonists such as Ozempic and Wegovy may help reduce alcohol consumption and related harms in individuals diagnosed with alcohol use disorder. Here ...

A recent poll found that about 15.5 million Americans have used injectable diabetes medicines like Ozempic and Wegovy to lose ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

A new study supports the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

A new spate of weight loss drugs like Ozempic and Wegovy is surging in popularity, but health experts caution they're not for ...

In fact, more and more teens that meet certain weight and health criteria are going on GLP-1s after the FDA’s approval of ...